A retrospective study based on FAERS database highlighted the incidence and severity of neutropenia, identifying fever and neutropenia as common fatal adverse events in PD-L1 monotherapy and the most prevalent fatal adverse events in PD-L1 combined with bevacizumab (83). Here, CD274 is linked to Decreased total neutrophil count.